French med tech company BIOMODEX has opened a new corporate headquarters in Quincy, Massachusetts. The new facility, which will house corporate offices and a state-of-the-art 3D printing laboratory, signals BIOMODEX’s entry into the U.S. market.
Based in Paris and supported by Dassault Systèmes, BIOMODEX is an innovator in the field of medical 3D printing, utilizing its technology to 3D print tissue-like anatomical twins based on patient-specific medical images. Notably, the company’s additive manufacturing platform is capable of creating realistic models, including complex blood vessels, which mimic the tactile feel and look of real anatomies.
The 3D printed model, based on MRIs and CT scans of specific patients are used by medical professionals to rehearse complex procedures, as well as to test new medical instruments and devices.
“We’re thrilled to find a home in the Boston-area among some of the world’s most innovative medical technology companies,” commented Thomas Marchand, CEO and co-founder of BIOMODEX. “Opening an operation in Massachusetts lays the groundwork for our continued growth and success by providing access to talent and ideas, and allows us to speed turn-around time for our North American customers.”
Manufacturing is reportedly already underway at the new facility in Quincy, just over 10 miles from Boston. In 2019, BIOMODEX says it plans to 3D print thousands of anatomical twins for North American physicians, health systems, researchers and medical device manufacturers. Over the course of the year, the med tech company also aims to increase its work force at the new U.S. location.
“Our vision is to reduce risk and improve patient outcomes by providing physicians an opportunity to test-drive procedures and train on new instruments and devices,” added Carolyn DeVasto, Vice President of Global Commercialization at BIOMODEX. “Our solution provides an industry that relies on their hands with the critical tactile feedback it needs.”
“We are pleased to welcome BIOMODEX into the rapidly growing community of Parisian start-ups with U.S. headquarters in New England,” concluded Arnaud Mentré, Consul General of France in Boston. “The company is a proud member of La FrenchTech Boston, which now represents more than 60 French entrepreneurs in the Greater Boston area. A vibrant example of the current dynamism of the French innovation scene, BIOMODEX intends to revolutionize interventional medicine with its 3D printed anatomical models.”